<p>InfuSystem Holdings, Inc. (NYSE:INFU - 獲取免費報告) 收到了五位分析師的平均推薦評級為 “買入”，MarketBeat 報道。一位投資分析師給予該股票持有評級，兩位給予買入評級，另外兩位則對該公司給予強烈買入評級。在過去一年中，發佈報告的經紀人對該股票的平均 12 個月目標價格為 15.00 美元。</p>
<ul>
<li>醫療設備的未來：你不能錯過的兩個強烈買入</li>
</ul>
<p>此外，Roth Mkm 在週二的研究報告中重申了 “買入” 評級，並將 InfuSystem 的目標價格設定為 15.00 美元。</p>
<p><strong>閲讀我們關於 INFU 的最新研究報告</strong></p>
<h2>機構投資者對 InfuSystem 的看法</h2>
<p>幾家機構投資者最近增加或減少了在 INFU 的持股。Minerva Advisors LLC 在第四季度將其在 InfuSystem 的持股增加了 5.2%。Minerva Advisors LLC 目前擁有 1,078,731 股該公司股票，價值 9,676,000 美元，此前在上個季度又購買了 52,942 股。Vanguard Group Inc. 在第三季度將其在 InfuSystem 的持股增加了 1.9%。Vanguard Group Inc. 目前擁有 976,177 股該公司股票，價值 10,113,000 美元，此前在上個季度又購買了 18,539 股。Punch &amp; Associates Investment Management Inc. 在第四季度將其在 InfuSystem 的持股增加了 1.9%。Punch &amp; Associates Investment Management Inc. 目前擁有 824,750 股該公司股票，價值 7,398,000 美元，此前在上個季度又收購了 15,000 股。Renaissance Technologies LLC 在第四季度將其在 InfuSystem 的持股增加了 2.0%。Renaissance Technologies LLC 目前擁有 587,509 股該公司股票，價值 5,270,000 美元，此前在上個季度又購買了 11,795 股。最後，Dimensional Fund Advisors LP 在第三季度將其在 InfuSystem 的持股增加了 0.8%。Dimensional Fund Advisors LP 目前擁有 569,238 股該公司股票，價值 5,898,000 美元，此前在上個季度又購買了 4,430 股。對沖基金和其他機構投資者持有該公司 71.13% 的股份。</p>
<h2>InfuSystem 股票表現</h2>
<p>在週二的午盤交易中，INFU 股票上漲了 1.02 美元，達到 8.60 美元。該公司的交易量為 180,783 股，而其平均交易量為 138,861 股。該股票的 50 日移動平均價格為 8.45 美元，200 日移動平均價格為 9.33 美元。InfuSystem 的一年低點為 4.61 美元，一年高點為 11.04 美元。該公司的債務與股本比率為 0.50，流動比率為 1.98，速動比率為 1.59。該公司的市值為 1.7489 億美元，市盈率為 143.36，貝塔值為 1.67。</p>
<h2>關於 InfuSystem</h2>
<p>(獲取免費報告)</p>
<p>InfuSystem Holdings Inc 是一家醫療技術公司，專注於租賃、管理和服務主要用於門診輸液治療的輸液泵及相關設備。該公司提供一整套服務，包括設備交付、安裝和回收、預防性和糾正性維護、再處理和質量保證。InfuSystem 的產品旨在幫助醫院、門診手術中心、腫瘤診所和私人輸液室簡化臨牀操作，並保持符合安全標準。</p>
<p>除了泵的租賃和維修服務外，InfuSystem 還擴展到了遠程患者監測解決方案。</p>
<h2>進一步閲讀</h2>
<ul>
<li>五隻我們更看好的股票，勝過 InfuSystem</li>
<li>這讓我感到憤怒</li>
<li>埃隆·馬斯克：這可能將 100 美元變成 100,000 美元</li>
<li>白銀支付 20% 的股息。此外還有 68% 的股價上漲</li>
<li>揭示：白宮背後正在發生重大事件</li>
<li>今年哪些費用可以從資本利得税中扣除？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlORlU?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlORlU"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 InfuSystem 嗎？</h2>
<p>在你考慮 InfuSystem 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前立即購買……而 InfuSystem 並不在名單上。</p>
<p>雖然 InfuSystem 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

InfuSystems控股

<p>InfuSystem Holdings, Inc.（紐約證券交易所代碼：INFU）獲得了五位分析師的平均 “買入” 推薦。該股票的 12 個月目標價為 15.00 美元。最近的機構投資包括 Minerva Advisors 將其持股增加 5.2%，以及 Vanguard Group 將其持股增加 1.9%。INFU 股票交易價格為 8.60 美元，市值為 1.7489 億美元。該公司專注於門診治療的輸液泵租賃和管理，並已擴展到遠程患者監測解決方案</p>

<p>InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) has been given an average recommendation of &#34;Buy&#34; by the five analysts that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, two have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $15.00.</p>
<div class="lb-trans"><p>InfuSystem Holdings, Inc. (NYSE:INFU - 獲取免費報告) 收到了五位分析師的平均推薦評級為 “買入”，MarketBeat 報道。一位投資分析師給予該股票持有評級，兩位給予買入評級，另外兩位則對該公司給予強烈買入評級。在過去一年中，發佈報告的經紀人對該股票的平均 12 個月目標價格為 15.00 美元。</p>
</div><ul>
<li>The Future of Medical Devices: Two Strong Buys You Can't Miss</li>
</ul>
<div class="lb-trans"><ul>
<li>醫療設備的未來：你不能錯過的兩個強烈買入</li>
</ul>
</div><p>Separately, Roth Mkm restated a &#34;buy&#34; rating and set a $15.00 price target on shares of InfuSystem in a research note on Tuesday.</p>
<div class="lb-trans"><p>此外，Roth Mkm 在週二的研究報告中重申了 “買入” 評級，並將 InfuSystem 的目標價格設定為 15.00 美元。</p>
</div><p><strong>Read Our Latest Research Report on INFU</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 INFU 的最新研究報告</strong></p>
</div><h2>Institutional Investors Weigh In On InfuSystem</h2>
<div class="lb-trans"><h2>機構投資者對 InfuSystem 的看法</h2>
</div><p>Several institutional investors have recently added to or reduced their stakes in INFU. Minerva Advisors LLC increased its stake in InfuSystem by 5.2% during the 4th quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company's stock valued at $9,676,000 after purchasing an additional 52,942 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of InfuSystem by 1.9% during the third quarter. Vanguard Group Inc. now owns 976,177 shares of the company's stock valued at $10,113,000 after buying an additional 18,539 shares during the last quarter. Punch &amp; Associates Investment Management Inc. increased its position in shares of InfuSystem by 1.9% during the fourth quarter. Punch &amp; Associates Investment Management Inc. now owns 824,750 shares of the company's stock valued at $7,398,000 after acquiring an additional 15,000 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of InfuSystem by 2.0% in the fourth quarter. Renaissance Technologies LLC now owns 587,509 shares of the company's stock worth $5,270,000 after purchasing an additional 11,795 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of InfuSystem by 0.8% during the third quarter. Dimensional Fund Advisors LP now owns 569,238 shares of the company's stock valued at $5,898,000 after purchasing an additional 4,430 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company's stock.</p>
<div class="lb-trans"><p>幾家機構投資者最近增加或減少了在 INFU 的持股。Minerva Advisors LLC 在第四季度將其在 InfuSystem 的持股增加了 5.2%。Minerva Advisors LLC 目前擁有 1,078,731 股該公司股票，價值 9,676,000 美元，此前在上個季度又購買了 52,942 股。Vanguard Group Inc. 在第三季度將其在 InfuSystem 的持股增加了 1.9%。Vanguard Group Inc. 目前擁有 976,177 股該公司股票，價值 10,113,000 美元，此前在上個季度又購買了 18,539 股。Punch &amp; Associates Investment Management Inc. 在第四季度將其在 InfuSystem 的持股增加了 1.9%。Punch &amp; Associates Investment Management Inc. 目前擁有 824,750 股該公司股票，價值 7,398,000 美元，此前在上個季度又收購了 15,000 股。Renaissance Technologies LLC 在第四季度將其在 InfuSystem 的持股增加了 2.0%。Renaissance Technologies LLC 目前擁有 587,509 股該公司股票，價值 5,270,000 美元，此前在上個季度又購買了 11,795 股。最後，Dimensional Fund Advisors LP 在第三季度將其在 InfuSystem 的持股增加了 0.8%。Dimensional Fund Advisors LP 目前擁有 569,238 股該公司股票，價值 5,898,000 美元，此前在上個季度又購買了 4,430 股。對沖基金和其他機構投資者持有該公司 71.13% 的股份。</p>
</div><h2>InfuSystem Price Performance</h2>
<div class="lb-trans"><h2>InfuSystem 股票表現</h2>
</div><p>INFU stock traded up $1.02 during midday trading on Tuesday, reaching $8.60. The company had a trading volume of 180,783 shares, compared to its average volume of 138,861. The stock has a 50 day moving average price of $8.45 and a 200-day moving average price of $9.33. InfuSystem has a 1-year low of $4.61 and a 1-year high of $11.04. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The company has a market capitalization of $174.89 million, a price-to-earnings ratio of 143.36 and a beta of 1.67.</p>
<div class="lb-trans"><p>在週二的午盤交易中，INFU 股票上漲了 1.02 美元，達到 8.60 美元。該公司的交易量為 180,783 股，而其平均交易量為 138,861 股。該股票的 50 日移動平均價格為 8.45 美元，200 日移動平均價格為 9.33 美元。InfuSystem 的一年低點為 4.61 美元，一年高點為 11.04 美元。該公司的債務與股本比率為 0.50，流動比率為 1.98，速動比率為 1.59。該公司的市值為 1.7489 億美元，市盈率為 143.36，貝塔值為 1.67。</p>
</div><h2>About InfuSystem</h2>
<div class="lb-trans"><h2>關於 InfuSystem</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem's offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.</p>
<div class="lb-trans"><p>InfuSystem Holdings Inc 是一家醫療技術公司，專注於租賃、管理和服務主要用於門診輸液治療的輸液泵及相關設備。該公司提供一整套服務，包括設備交付、安裝和回收、預防性和糾正性維護、再處理和質量保證。InfuSystem 的產品旨在幫助醫院、門診手術中心、腫瘤診所和私人輸液室簡化臨牀操作，並保持符合安全標準。</p>
</div><p>In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.</p>
<div class="lb-trans"><p>除了泵的租賃和維修服務外，InfuSystem 還擴展到了遠程患者監測解決方案。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than InfuSystem</li>
<li>This makes me furious</li>
<li>Elon Musk: This Could Turn $100 into $100,000</li>
<li>Silver paying 20% dividend. Plus 68% share gains</li>
<li>REVEALED: Something Big Happening Behind White House Doors</li>
<li>What Expenses Can Be Deducted From Capital Gains Tax This Year?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 InfuSystem</li>
<li>這讓我感到憤怒</li>
<li>埃隆·馬斯克：這可能將 100 美元變成 100,000 美元</li>
<li>白銀支付 20% 的股息。此外還有 68% 的股價上漲</li>
<li>揭示：白宮背後正在發生重大事件</li>
<li>今年哪些費用可以從資本利得税中扣除？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlORlU" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=INFU"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in InfuSystem Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 InfuSystem 嗎？</h2>
</div><p>Before you consider InfuSystem, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 InfuSystem 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InfuSystem wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前立即購買……而 InfuSystem 並不在名單上。</p>
</div><p>While InfuSystem currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 InfuSystem 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

InfuSystem 控股公司（NYSE: INFU）被券商給予平均 “買入” 評級